The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global miRNA Sequencing and Assay Market Research Report 2024

Global miRNA Sequencing and Assay Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1719471

No of Pages : 86

Ask Your Query

Synopsis

A microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals and some viruses, that functions in RNA silencing and post-transcriptional regulation of gene expression.

The global miRNA Sequencing and Assay market was valued at US$ 252.3 million in 2023 and is anticipated to reach US$ 491 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.

North American market for miRNA Sequencing and Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for miRNA Sequencing and Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for miRNA Sequencing and Assay in Clinical Medical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of miRNA Sequencing and Assay include Illumina, Thermo Fisher Scientific, Qiagen, Perkinelmer, Takara Bio, Ew England Biolabs, Norgen Biotek Corporation, Rilink Biotechnologies and Exogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for miRNA Sequencing and Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding miRNA Sequencing and Assay.

Report Scope

The miRNA Sequencing and Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global miRNA Sequencing and Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the miRNA Sequencing and Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Illumina
  • Thermo Fisher Scientific
  • Qiagen
  • Perkinelmer
  • Takara Bio
  • Ew England Biolabs
  • Norgen Biotek Corporation
  • Rilink Biotechnologies
  • Exogen
  • Oxford Nanopore Technologies

Segment by Type

  • Sequencing By Synthesis
  • Nanopore
  • Ion Semiconductor Sequencing

Segment by Application

  • Clinical Medical
  • Biological Research

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of miRNA Sequencing and Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global miRNA Sequencing and Assay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sequencing By Synthesis
1.2.3 Nanopore
1.2.4 Ion Semiconductor Sequencing
1.3 Market by Application
1.3.1 Global miRNA Sequencing and Assay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Medical
1.3.3 Biological Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global miRNA Sequencing and Assay Market Perspective (2019-2030)
2.2 miRNA Sequencing and Assay Growth Trends by Region
2.2.1 Global miRNA Sequencing and Assay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 miRNA Sequencing and Assay Historic Market Size by Region (2019-2024)
2.2.3 miRNA Sequencing and Assay Forecasted Market Size by Region (2025-2030)
2.3 miRNA Sequencing and Assay Market Dynamics
2.3.1 miRNA Sequencing and Assay Industry Trends
2.3.2 miRNA Sequencing and Assay Market Drivers
2.3.3 miRNA Sequencing and Assay Market Challenges
2.3.4 miRNA Sequencing and Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top miRNA Sequencing and Assay Players by Revenue
3.1.1 Global Top miRNA Sequencing and Assay Players by Revenue (2019-2024)
3.1.2 Global miRNA Sequencing and Assay Revenue Market Share by Players (2019-2024)
3.2 Global miRNA Sequencing and Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by miRNA Sequencing and Assay Revenue
3.4 Global miRNA Sequencing and Assay Market Concentration Ratio
3.4.1 Global miRNA Sequencing and Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by miRNA Sequencing and Assay Revenue in 2023
3.5 miRNA Sequencing and Assay Key Players Head office and Area Served
3.6 Key Players miRNA Sequencing and Assay Product Solution and Service
3.7 Date of Enter into miRNA Sequencing and Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 miRNA Sequencing and Assay Breakdown Data by Type
4.1 Global miRNA Sequencing and Assay Historic Market Size by Type (2019-2024)
4.2 Global miRNA Sequencing and Assay Forecasted Market Size by Type (2025-2030)
5 miRNA Sequencing and Assay Breakdown Data by Application
5.1 Global miRNA Sequencing and Assay Historic Market Size by Application (2019-2024)
5.2 Global miRNA Sequencing and Assay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America miRNA Sequencing and Assay Market Size (2019-2030)
6.2 North America miRNA Sequencing and Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America miRNA Sequencing and Assay Market Size by Country (2019-2024)
6.4 North America miRNA Sequencing and Assay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe miRNA Sequencing and Assay Market Size (2019-2030)
7.2 Europe miRNA Sequencing and Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe miRNA Sequencing and Assay Market Size by Country (2019-2024)
7.4 Europe miRNA Sequencing and Assay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific miRNA Sequencing and Assay Market Size (2019-2030)
8.2 Asia-Pacific miRNA Sequencing and Assay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific miRNA Sequencing and Assay Market Size by Region (2019-2024)
8.4 Asia-Pacific miRNA Sequencing and Assay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America miRNA Sequencing and Assay Market Size (2019-2030)
9.2 Latin America miRNA Sequencing and Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America miRNA Sequencing and Assay Market Size by Country (2019-2024)
9.4 Latin America miRNA Sequencing and Assay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa miRNA Sequencing and Assay Market Size (2019-2030)
10.2 Middle East & Africa miRNA Sequencing and Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa miRNA Sequencing and Assay Market Size by Country (2019-2024)
10.4 Middle East & Africa miRNA Sequencing and Assay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina miRNA Sequencing and Assay Introduction
11.1.4 Illumina Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific miRNA Sequencing and Assay Introduction
11.2.4 Thermo Fisher Scientific Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen miRNA Sequencing and Assay Introduction
11.3.4 Qiagen Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.3.5 Qiagen Recent Development
11.4 Perkinelmer
11.4.1 Perkinelmer Company Detail
11.4.2 Perkinelmer Business Overview
11.4.3 Perkinelmer miRNA Sequencing and Assay Introduction
11.4.4 Perkinelmer Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.4.5 Perkinelmer Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Detail
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio miRNA Sequencing and Assay Introduction
11.5.4 Takara Bio Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.5.5 Takara Bio Recent Development
11.6 Ew England Biolabs
11.6.1 Ew England Biolabs Company Detail
11.6.2 Ew England Biolabs Business Overview
11.6.3 Ew England Biolabs miRNA Sequencing and Assay Introduction
11.6.4 Ew England Biolabs Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.6.5 Ew England Biolabs Recent Development
11.7 Norgen Biotek Corporation
11.7.1 Norgen Biotek Corporation Company Detail
11.7.2 Norgen Biotek Corporation Business Overview
11.7.3 Norgen Biotek Corporation miRNA Sequencing and Assay Introduction
11.7.4 Norgen Biotek Corporation Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.7.5 Norgen Biotek Corporation Recent Development
11.8 Rilink Biotechnologies
11.8.1 Rilink Biotechnologies Company Detail
11.8.2 Rilink Biotechnologies Business Overview
11.8.3 Rilink Biotechnologies miRNA Sequencing and Assay Introduction
11.8.4 Rilink Biotechnologies Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.8.5 Rilink Biotechnologies Recent Development
11.9 Exogen
11.9.1 Exogen Company Detail
11.9.2 Exogen Business Overview
11.9.3 Exogen miRNA Sequencing and Assay Introduction
11.9.4 Exogen Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.9.5 Exogen Recent Development
11.10 Oxford Nanopore Technologies
11.10.1 Oxford Nanopore Technologies Company Detail
11.10.2 Oxford Nanopore Technologies Business Overview
11.10.3 Oxford Nanopore Technologies miRNA Sequencing and Assay Introduction
11.10.4 Oxford Nanopore Technologies Revenue in miRNA Sequencing and Assay Business (2019-2024)
11.10.5 Oxford Nanopore Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock